These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30734113)

  • 41. (18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.
    Gao A; Wang S; Fu Z; Sun X; Yu J; Meng X
    Int J Clin Exp Med; 2015; 8(5):7561-8. PubMed ID: 26221300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic Tumor Burden Assessed by Dual Time Point [
    Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
    Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.
    Schaefer A; Vermandel M; Baillet C; Dewalle-Vignion AS; Modzelewski R; Vera P; Massoptier L; Parcq C; Gibon D; Fechter T; Nemer U; Gardin I; Nestle U
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):911-924. PubMed ID: 26567163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer.
    Frings V; de Langen AJ; Smit EF; van Velden FH; Hoekstra OS; van Tinteren H; Boellaard R
    J Nucl Med; 2010 Dec; 51(12):1870-7. PubMed ID: 21078791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insight on automated lesion delineation methods for PET data.
    Firouzian A; Kelly MD; Declerck JM
    EJNMMI Res; 2014; 4():69. PubMed ID: 25593791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
    Duan Y; Li J; Zhang Y; Wang W; Sun X; Fan T; Shao Q; Xu M; Guo Y; Shang D
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):623-30. PubMed ID: 25754243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.
    Hapdey S; Edet-Sanson A; Gouel P; Martin B; Modzelewski R; Baron M; Berghian A; Forestier-Lebreton F; Georgescu D; Picquenot JM; Gardin I; Dubray B; Vera P
    Radiother Oncol; 2014 Sep; 112(3):407-12. PubMed ID: 25216573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology.
    Anouan KJ; Lelandais B; Edet-Sanson A; Ruan S; Vera P; Gardin I; Hapdey S
    Q J Nucl Med Mol Imaging; 2017 Sep; 61(3):301-313. PubMed ID: 26407135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does enhanced CT influence the biological GTV measurement on FDG-PET images?
    Vera P; Modzelewski R; Hapdey S; Gouel P; Tilly H; Jardin F; Ruan S; Gardin I
    Radiother Oncol; 2013 Jul; 108(1):86-90. PubMed ID: 23618503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative
    de Heer EC; Brouwers AH; Boellaard R; Sluiter WJ; Diercks GFH; Hospers GAP; de Vries EGE; Jalving M
    EJNMMI Res; 2018 Nov; 8(1):101. PubMed ID: 30460579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease quantification on PET/CT images without explicit object delineation.
    Tong Y; Udupa JK; Odhner D; Wu C; Schuster SJ; Torigian DA
    Med Image Anal; 2019 Jan; 51():169-183. PubMed ID: 30453165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcentimeter tumor lesion delineation for high-resolution 18F-FDG PET images: optimizing correction for partial-volume effects.
    Wallstén E; Axelsson J; Sundström T; Riklund K; Larsson A
    J Nucl Med Technol; 2013 Jun; 41(2):85-91. PubMed ID: 23658206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Machine-learned target volume delineation of
    Parkinson C; Evans M; Guerrero-Urbano T; Michaelidou A; Pike L; Barrington S; Jayaprakasam V; Rackley T; Palaniappan N; Staffurth J; Marshall C; Spezi E
    Phys Med; 2019 May; 61():85-93. PubMed ID: 31151585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of a proposed updated EARL harmonization of
    Ly J; Minarik D; Edenbrandt L; Wollmer P; Trägårdh E
    EJNMMI Res; 2019 Jul; 9(1):65. PubMed ID: 31346805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology.
    Cheebsumon P; Boellaard R; de Ruysscher D; van Elmpt W; van Baardwijk A; Yaqub M; Hoekstra OS; Comans EF; Lammertsma AA; van Velden FH
    EJNMMI Res; 2012 Oct; 2(1):56. PubMed ID: 23034289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT.
    Skretting A; Evensen JF; Løndalen AM; Bogsrud TV; Glomset OK; Eilertsen K
    Acta Oncol; 2013 Apr; 52(3):636-44. PubMed ID: 23075421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiotherapy volume delineation based on (
    Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U
    Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.